Airfinity welcomes some of the leading experts across the life science space to a live industry roundtable, where they discussed pre-emptive health economics, the role of forecasting in improving disease outcomes and the strategies needed to reduce disease burden.

Speakers include:

→ Sasha Siegel, PhD, VP of Disease Outcomes at Airfinity
→ Matt Linley, PhD, Senior Director, Analytics and Forecasting at Airfinity
→ Sir Peter Donnelly, CEO and Founder of Genomics Plc and Emeritus Professor of Statistical Science at the University of Oxford
→ Prof. Lotte Steuten, PhD, Deputy Chief Executive of the Office of Health Economics (OHE)
→ Jean-Bernard Gruenberger, Director for Value & Access, Novartis Global Health

Airfinity welcomes some of the leading experts across the life science space to a live industry roundtable, where they discussed pre-emptive health economics, the role of forecasting in improving disease outcomes and the strategies needed to reduce disease burden.

Speakers include:

→ Sasha Siegel, PhD, VP of Disease Outcomes at Airfinity
→ Matt Linley, PhD, Senior Director, Analytics and Forecasting at Airfinity
→ Sir Peter Donnelly, CEO and Founder of Genomics Plc and Emeritus Professor of Statistical Science at the University of Oxford
→ Prof. Lotte Steuten, PhD, Deputy Chief Executive of the Office of Health Economics (OHE)
→ Jean-Bernard Gruenberger, Director for Value & Access, Novartis Global Health